Buy Mounjaro Online 5mg

Mounjaro – Once-Weekly Dual GIP/GLP-1 Receptor Agonist Injection

Mounjaro is the pioneering once-weekly injectable prescription medicine from Eli Lilly, containing tirzepatide, the first and only approved dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This innovative 39-amino-acid modified peptide (with Aib substitutions, C-terminal amide, and C20 fatty diacid acylation for extended half-life) delivers powerful glycemic control while supporting meaningful weight reduction in clinical studies—making it a cornerstone therapy for adults and children 10 years and older with type 2 diabetes.

Administered subcutaneously via a convenient pre-filled single-dose pen, Mounjaro works by enhancing insulin secretion in a glucose-dependent manner, reducing glucagon levels, slowing gastric emptying, and promoting satiety to help manage blood sugar effectively when used alongside diet and exercise.

Key Benefits & Clinical Effects:

• Superior A1C Reduction — Proven to significantly lower HbA1c levels (often superior to other incretin therapies in head-to-head trials) for better long-term glycemic control in type 2 diabetes.
• Substantial Weight Loss Support — Drives notable body weight reduction (frequently 15–20%+ in many patients over extended periods) through appetite suppression, reduced food intake, and improved metabolic efficiency—beyond typical diabetes management.
• Glucose-Dependent Action — Stimulates first- and second-phase insulin release while suppressing inappropriate glucagon, minimizing hypoglycemia risk when not combined with insulin or sulfonylureas.
• Cardiometabolic Advantages — Supports improvements in lipid profiles, blood pressure, and overall metabolic health in relevant studies.
• Convenient Once-Weekly Dosing — Flexible administration any time of day, with or without meals, in the abdomen, thigh, or upper arm.

Product Highlights:

• Available in pre-filled, single-dose or pen formats with strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL
• Clear, colorless to slightly yellow, sterile, preservative-free solution
• Starting dose typically 2.5 mg once weekly, titrated in 2.5 mg increments (after ≥4 weeks) up to a maximum of 15 mg weekly for individualized control
• Ready-to-use—no reconstitution required

Mounjaro is a prescription weight loss injection available. It can help you lose 22.5% of your starting weight on average when used alongside a diet and exercise plan. Mounjaro treatment may be right for you if your BMI is 30 or more, or 27 or more, and you have a weight-related health condition, like high blood pressure.

Each Mounjaro pen contains 4 doses of the active ingredient tirzepatide, which reduces your appetite and makes you feel fuller for longer. Mounjaro is manufactured by Eli Lilly.

All of our advice and treatments are for your personal use only.

Mounjaro is available as part of our weight loss service. We provide:

• free advice, support, & aftercare from our doctors
• hassle-free online consultation (no need to see a doctor in person)
• nutritional guidance from our in-house team, weight loss trackers, and diaries to keep you on track
• convenient collection at an Asda pharmacy – same day if approved before 3pm, or next day after 3pm – or discreet next-day delivery to your address
• treatment with no hidden fees or additional costs
• free needles for your injections, with sharps bins available on request

Already using Apex weight loss service?

We’ve got a list of frequently asked questions about our service for you to check in case you need any extra guidance:

Serious Side Effects

Mounjaro may cause serious side effects, including:

Inflammation of the pancreas (Pancreatitis)

Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back.

Low blood sugar (hypoglycemia)

Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs or symptoms of low blood sugar levels may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness, and feeling jittery.

Serious allergic reactions (anaphylaxis)

Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and a very rapid heartbeat.

Dehydration leading to kidney problems

Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. You need to drink fluids to help reduce your chance of dehydration.

Severe stomach problems

Stomach problems, sometimes severe, have been reported in people who use Mounjaro. Tell your healthcare provider if you have stomach problems that are severe or will not go away.

Changes in vision

Tell your healthcare provider if you have changes in vision during treatment with Mounjaro, such as sudden vision changes, vision loss, blind spots in your visual field, or difficulty seeing colors.

Gallbladder problems

Gallbladder problems have happened in some people who use Mounjaro. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.